Skip to main content
. 2016 Oct 19;11(10):e0164921. doi: 10.1371/journal.pone.0164921

Fig 1. The survival of patients with MBC and IDC by Kaplan-Meier analysis.

Fig 1

Patients with MBC obviously had better survival (HR = 0.26; 95% CI, 0.21–0.31, and P < 0.001) with 5- and 10-year CSS rates of 98.23% and 96.03% versus 91.44% and 85.48% in patients with IDC, respectively. IDC: infiltrative ductal cancer; MBC: mucinous breast cancer; and CSS: cancer specific survival.